UBTECH’s U1 full-size companion humanoid robot has accumulated more than 5,000 pre-orders on JD.com and Tmall within three weeks of its early June launch – a figure that nearly equals five times the company’s entire 2025 full-size humanoid robot sales volume of 1,079 units. The result is an early commercial signal that Chinese consumers are willing to purchase full-size humanoid robots for home use at prices well above those of the smaller companion robots that have previously defined the consumer robotics market.
The U1 comes in male and female versions, each equipped with 88 high-degree-of-freedom motion joints and designed primarily for emotional companionship. UBTECH is targeting production of 10,000 U1 units in 2026 alongside a parallel target of 10,000 industrial humanoid robots from its Walker S series.
Consumer vs Industrial Strategy
UBTECH’s stated three-step commercialization strategy prioritizes industrial deployment first, followed by commercial service environments, and eventually home companionship. The early U1 consumer launch appears to represent a pragmatic acceleration of the third step – driven by competitive pressure from faster-moving rivals and the commercial opportunity signaled by demand for GigaAI’s SeeLight S1 and the broader interest in home robotics among Chinese consumers.
The competitive pressure is significant. Unitree achieved 60% gross margins in its humanoid business through aggressive cost reduction, with its G1 model starting at under 100,000 yuan compared to UBTECH’s 2025 average humanoid robot price of 760,000 yuan. Zhiyuan Robot shipped 5,100 units in 2025 and is targeting tens of thousands in 2026. The gap between UBTECH’s pricing and Unitree’s in the consumer segment is a structural challenge the U1 launch does not yet resolve.
Full-Stack Development and Financial Position
UBTECH has pursued a full-stack approach to humanoid development, building its own Thinker embodied large model, BrainNet 2.0 swarm intelligence network, and joint motors in-house. That vertical integration has driven R&D spending to 507 million yuan in 2025 – significantly higher than peers as a percentage of revenue – and contributed to continued losses.
The company reported net losses of 703 million yuan in 2025, narrowing from 1.12 billion yuan in 2024, on revenue of 2.0 billion yuan. Accounts receivable stood at 1.3 billion yuan, with more than 40% aged beyond one year due to concentration among government customers who pay on extended timelines. Operating cash outflows continued at 780 million yuan.
The U1’s pre-order performance does not resolve those financial pressures, but it provides a commercial data point that the consumer humanoid market may develop faster than the industry had assumed. UBTECH founder Zhou Jian has set ambitious shipment targets: “Based on publicly disclosed orders and bid wins, whether by single contract value or cumulative total, we may be the global No. 1.” Whether the 5,000 U1 pre-orders convert to delivered units and satisfied customers – and at what margin – will determine whether the consumer pivot strengthens or strains the company’s position further.
